Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.

Park JS, Lim HJ, Cho YJ, Lee JH, Yoon HI, Lee CT.

COPD. 2012 Aug;9(5):499-504. doi: 10.3109/15412555.2012.694922. Epub 2012 Sep 4.

PMID:
22946546
2.

Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Goudie AR, Lipworth BJ, Hopkinson PJ, Wei L, Struthers AD.

Lancet Respir Med. 2014 Apr;2(4):293-300. doi: 10.1016/S2213-2600(14)70013-X. Epub 2014 Mar 5.

3.

Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients.

Kruis AL, van Adrichem J, Erkelens MR, Scheepers H, In 't Veen H, Muris JW, Chavannes NH.

Int J Chron Obstruct Pulmon Dis. 2010 Nov 25;5:407-13. doi: 10.2147/COPD.S9654.

4.

PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.

Kim KH, Kim HK, Hwang IC, Cho HJ, Je N, Kwon OM, Choi SJ, Lee SP, Kim YJ, Sohn DW.

Am Heart J. 2015 Jun;169(6):813-822.e3. doi: 10.1016/j.ahj.2015.03.018. Epub 2015 Apr 1.

PMID:
26027619
5.

Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.

Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE.

J Pain Symptom Manage. 2012 Apr;43(4):706-19. doi: 10.1016/j.jpainsymman.2011.05.007. Epub 2011 Dec 14.

PMID:
22168961
6.

Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.

Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.

Clin Ther. 2011 Dec;33(12):1974-84. doi: 10.1016/j.clinthera.2011.11.009.

PMID:
22177371
7.

Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.

Foglio K, Bianchi L, Bruletti G, Porta R, Vitacca M, Balbi B, Ambrosino N.

Respir Med. 2007 Sep;101(9):1961-70. Epub 2007 May 24.

8.

Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide.

Dummer JF, Epton MJ, Cowan JO, Cook JM, Condliffe R, Landhuis CE, Smith AD, Taylor DR.

Am J Respir Crit Care Med. 2009 Nov 1;180(9):846-52. doi: 10.1164/rccm.200905-0685OC. Epub 2009 Aug 6.

PMID:
19661244
9.

Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

Lee TM, Chen CC, Shen HN, Chang NC.

Clin Sci (Lond). 2009 Mar;116(6):497-505. doi: 10.1042/CS20080241.

PMID:
18831711
10.

A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT).

Suzuki M, Muro S, Ando Y, Omori T, Shiota T, Endo K, Sato S, Aihara K, Matsumoto M, Suzuki S, Itotani R, Ishitoko M, Hara Y, Takemura M, Ueda T, Kagioka H, Hirabayashi M, Fukui M, Mishima M.

Arch Intern Med. 2012 Jun 11;172(11):878-86.

PMID:
22905352
11.

Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease.

Umehara M, Yamaguchi A, Itakura S, Suenaga M, Sakaki Y, Nakashiki K, Miyata M, Tei C.

J Cardiol. 2008 Apr;51(2):106-13. doi: 10.1016/j.jjcc.2008.01.004.

12.

[Functional status and survival in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation].

López Varela MV, Anido T, Larrosa M.

Arch Bronconeumol. 2006 Sep;42(9):434-9. Spanish.

14.

[Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].

Ozgur ES, Atis S, Kanik A.

Tuberk Toraks. 2008;56(3):296-303. Turkish.

PMID:
18932031
15.

Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.

Satake M, Takahashi H, Sugawara K, Kawagoshi A, Tamaki A, Homma M, Morita R, Sato K, Sano M, Shioya T.

Arzneimittelforschung. 2011;61(1):8-13. doi: 10.1055/s-0031-1296162.

PMID:
21355441
16.

[Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors].

Wang T, Mao Y, Sun Y, Hou W, Feng Y, Qu H.

Zhonghua Nei Ke Za Zhi. 2015 Dec;54(12):1037-40. Chinese.

PMID:
26887371
17.

[Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].

Chlumský J, Stĕrbová L, Smolíková L, Matous M, Salajka F.

Vnitr Lek. 2002 Apr;48(4):320-4. Czech.

PMID:
12061182
18.

Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).

Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K.

Osaka City Med J. 2011 Jun;57(1):21-9.

PMID:
22106764
19.

Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.

Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE.

Thorax. 2008 Jul;63(7):606-13. doi: 10.1136/thx.2007.085993. Epub 2008 Feb 4.

PMID:
18250181
20.

Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation.

Baltzan MA, Scott AS, Wolkove N, Bailes S, Bernard S, Bourbeau J, Maltais F; Canadian COPD Pulmonary Rehabilitation Research Group.

Chron Respir Dis. 2011;8(2):119-28. doi: 10.1177/1479972310396737. Epub 2011 Mar 23.

PMID:
21430090

Supplemental Content

Support Center